Access cutting-edge type 1 diabetes treatment through this clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.
Access type 1 diabetes specialists in Atlanta at no cost
This study follows strict safety protocols and ethical guidelines
All study-related type 1 diabetes treatment provided free
This is a randomized, placebo-controlled, parallel group, multicenter, double-blind Phase 2a, 2-arm study. The goal of this Phase 2a study is to assess safety and efficacy of SAR442970 in comparison to placebo to preserve β-cell function in participants with recently diagnosed type 1 diabetes (T1D) on insulin therapy. The study design comprises 2 parts: in Part A adult participants (18 to 35 years of age at screening) and in Part B adolescent and young adult participants (age range 12 to 21 ye
Sponsor: Sanofi
Check if you qualify for this type 1 diabetes clinical trial in Atlanta, GA
If you're searching for type 1 diabetes treatment options in Atlanta, GA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Atlanta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 1 diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.